(Q34458059)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585882%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

review article

1 reference

title

Endocannabinoid signalling in innate and adaptive immunity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585882%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585882%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Luca Battistini

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585882%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Mauro Maccarrone

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585882%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

publication date

1 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585882%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585882%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

144

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585882%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585882%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

352-364

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585882%20AND%20SRC:MED&resulttype=core&format=json

Anandamide, an endogenous cannabinomimetic eicosanoid: 'killing two birds with one stone'.

27 February 2020

cites work

1 reference

Endocannabinoids, related compounds and their metabolic routes.

21 January 2018

1 reference

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

21 January 2018

1 reference

Biological functions and metabolism of oleoylethanolamide

21 January 2018

1 reference

Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism.

21 January 2018

1 reference

Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain

21 January 2018

1 reference

Evidence for the intracellular accumulation of anandamide in adiposomes.

21 January 2018

1 reference

Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins

21 January 2018

1 reference

Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2.

21 January 2018

1 reference

Intracellular trafficking of anandamide: new concepts for signaling.

21 January 2018

1 reference

Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways

21 January 2018

1 reference

Molecular characterization of a phospholipase D generating anandamide and its congeners

21 January 2018

1 reference

Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D

21 January 2018

1 reference

Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contribute to endocannabinoid production in vivo

21 January 2018

1 reference

A biosynthetic pathway for anandamide

21 January 2018

1 reference

Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain

21 January 2018

1 reference

2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain

21 January 2018

1 reference

Structure and function of fatty acid amide hydrolase

21 January 2018

1 reference

A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol

21 January 2018

1 reference

The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors

21 January 2018

1 reference

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂

21 January 2018

1 reference

Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease

21 January 2018

1 reference

Identification and functional characterization of brainstem cannabinoid CB2 receptors

21 January 2018

1 reference

Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain

21 January 2018

1 reference

CB2: a cannabinoid receptor with an identity crisis

21 January 2018

1 reference

Cannabinoid CB(2) receptors in health and disease.

21 January 2018

1 reference

Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation.

21 January 2018

1 reference

Endocannabinoids as regulators of transient receptor potential (TRP) channels: A further opportunity to develop new endocannabinoid-based therapeutic drugs

21 January 2018

1 reference

Monoacylglycerols activate TRPV1--a link between phospholipase C and TRPV1

21 January 2018

1 reference

TRPV1 signaling: mechanistic understanding and therapeutic potential

21 January 2018

1 reference

From surface to nuclear receptors: the endocannabinoid family extends its assets

21 January 2018

1 reference

GPR55: Current Knowledge and Future Perspectives of a Purported “Type-3” Cannabinoid Receptor

21 January 2018

1 reference

The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases

21 January 2018

1 reference

Endocannabinoids and immune regulation

21 January 2018

1 reference

The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease

21 January 2018

1 reference

CB(1) and CB(2) receptor-mediated signalling: a focus on endocannabinoids

21 January 2018

1 reference

Cannabinoid-receptor expression in human leukocytes

21 January 2018

1 reference

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

21 January 2018

1 reference

Differential expression of cannabinoid CB(2) receptor mRNA in mouse immune cell subpopulations and following B cell stimulation

21 January 2018

1 reference

Detailed characterisation of CB2 receptor protein expression in peripheral blood immune cells from healthy human volunteers using flow cytometry

21 January 2018

1 reference

Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors

21 January 2018

1 reference

Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation.

21 January 2018

1 reference

2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1.

21 January 2018

1 reference

Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol

21 January 2018

1 reference

2-Arachidonoyl-glycerol suppresses interferon-gamma production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2.

21 January 2018

1 reference

Of mice and not men: differences between mouse and human immunology

21 January 2018

1 reference

Monocytes and macrophages: developmental pathways and tissue homeostasis

21 January 2018

1 reference

Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages

21 January 2018

1 reference

Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.

21 January 2018

1 reference

Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages

21 January 2018

1 reference

Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages

21 January 2018

1 reference

Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor.

21 January 2018

1 reference

Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes

21 January 2018

1 reference

Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids.

21 January 2018

1 reference

Proinflammatory stimuli control N-acylphosphatidylethanolamine-specific phospholipase D expression in macrophages

21 January 2018

1 reference

Evidence for bidirectional endocannabinoid transport across cell membranes

21 January 2018

1 reference

Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation

21 January 2018

1 reference

Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells

21 January 2018

1 reference

Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide.

21 January 2018

1 reference

Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2).

21 January 2018

1 reference

Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK, and NF-kappaB.

21 January 2018

1 reference

The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells.

21 January 2018

1 reference

CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.

21 January 2018

1 reference

Involvement of cannabinoid receptor CB2 in dectin-1-mediated macrophage phagocytosis

21 January 2018

1 reference

Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 and Streptococcus pneumoniae R6 by microglial cells

21 January 2018

1 reference

Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections

21 January 2018

1 reference

Mast cells, glia and neuroinflammation: partners in crime?

21 January 2018

1 reference

2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice

21 January 2018

1 reference

Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis

21 January 2018

1 reference

2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells

21 January 2018

1 reference

2-Arachidonoylglycerol Induces the Migration of HL-60 Cells Differentiated into Macrophage-like Cells and Human Peripheral Blood Monocytes through the Cannabinoid CB2 Receptor-dependent Mechanism

21 January 2018

1 reference

2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, enhances the adhesion of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes

21 January 2018

1 reference

COX-2-derived endocannabinoid metabolites as novel inflammatory mediators.

21 January 2018

1 reference

The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting

21 January 2018

1 reference

Presence and regulation of the endocannabinoid system in human dendritic cells

21 January 2018

1 reference

Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation

21 January 2018

1 reference

Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection

21 January 2018

1 reference

Anandamide prior to sensitization increases cell-mediated immunity in mice.

21 January 2018

1 reference

Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis

21 January 2018

1 reference

Diverse novel functions of neutrophils in immunity, inflammation, and beyond

21 January 2018

1 reference

Innate or adaptive immunity? The example of natural killer cells

21 January 2018

1 reference

New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation

21 January 2018

1 reference

Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells.

21 January 2018

1 reference

Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2.

21 January 2018

1 reference

Anandamide and neutrophil function in patients with fibromyalgia

21 January 2018

1 reference

Cannabinoid receptor-independent suppression of the superoxide generation of human neutrophils (PMN) by CP55 940, but not by anandamide.

21 January 2018

1 reference

Indirect CB2 receptor and mediator-dependent stimulation of human whole-blood neutrophils by exogenous and endogenous cannabinoids.

21 January 2018

1 reference

The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques.

21 January 2018

1 reference

2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV.

21 January 2018

1 reference

Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils

21 January 2018

1 reference

Protective and pathological roles of mast cells and basophils

21 January 2018

1 reference

The expanding role(s) of eosinophils in health and disease

21 January 2018

1 reference

2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils

21 January 2018

1 reference

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

21 January 2018

1 reference

Palmitoylethanolamide regulates development of intestinal radiation injury in a mast cell-dependent manner

21 January 2018

1 reference

New insights in mast cell modulation by palmitoylethanolamide

21 January 2018

1 reference

The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors

21 January 2018

1 reference

Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury.

21 January 2018

1 reference

Non-neuronal cell modulation relieves neuropathic pain: efficacy of the endogenous lipid palmitoylethanolamide.

21 January 2018

1 reference

Endocannabinoid degradation, endotoxic shock and inflammation.

21 January 2018

1 reference

Endocannabinoids limit excessive mast cell maturation and activation in human skin

21 January 2018

1 reference

Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ

21 January 2018

1 reference

Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1.

21 January 2018

1 reference

The functional plasticity of T cell subsets

21 January 2018

1 reference

Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis

21 January 2018

1 reference

Anandamide attenuates Th-17 cell-mediated delayed-type hypersensitivity response by triggering IL-10 production and consequent microRNA induction

21 January 2018

1 reference

Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid receptor-independent pathway.

21 January 2018

1 reference

A COX-2 metabolite of the endogenous cannabinoid, 2-arachidonyl glycerol, mediates suppression of IL-2 secretion in activated Jurkat T cells

21 January 2018

1 reference

Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes

21 January 2018

1 reference

Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis

21 January 2018

1 reference

Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.

21 January 2018

1 reference

Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility

21 January 2018

1 reference

Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders

21 January 2018

1 reference

Formation of B and T cell subsets require the cannabinoid receptor CB2.

21 January 2018

1 reference

B-cell biology and development

21 January 2018

1 reference

Identification of transcription start sites and preferential expression of select CB2 transcripts in mouse and human B lymphocytes

21 January 2018

1 reference

Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids

21 January 2018

1 reference

Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone

21 January 2018

1 reference

Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in cultures of murine-purified B lymphocytes

21 January 2018

1 reference

Induction of preferential chemotaxis of unstimulated B-lymphocytes by 2-arachidonoylglycerol in immunized mice

21 January 2018

1 reference

The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4557672

GPR55: Current knowledge and future perspectives of a purported "Type-3" cannabinoid receptor

18 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4557672

The endocannabinoid anandamide neither impairs in vitro T-cell function nor induces regulatory T-cell generation.

18 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4557672

Role of endocannabinoids and their analogues in obesity and eating disorders

18 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4557672

Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2.

18 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4557672

The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein

18 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4557672

Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility.

18 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4557672

Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation.

18 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4557672

Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells

18 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4557672

Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: comparison with other eosinophil chemoattractants

18 November 2018

1 reference

12 December 2020

Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by interferon-β: a longitudinal study in multiple sclerosis patients

1 reference

12 December 2020

2-Arachidonoylglycerol enhances the phagocytosis of opsonized zymosan by HL-60 cells differentiated into macrophage-like cells

1 reference

12 December 2020

The endocannabinoid 2-arachidonoyl-glycerol activates human neutrophils: critical role of its hydrolysis and de novo leukotriene B4 biosynthesis

1 reference

12 December 2020

Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells

1 reference

12 December 2020

Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice

1 reference

12 December 2020

Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells

1 reference

12 December 2020

Mechanisms of human eosinophil migration induced by the combination of IL-5 and the endocannabinoid 2-arachidonoyl-glycerol

1 reference

12 December 2020

Identifiers

DOI

10.1111/IMM.12441

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585882%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

PMC publication ID

4557672

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585882%20AND%20SRC:MED&resulttype=core&format=json